Table 1.
Data used for testing model/matrices
| Observed baseline prevalence (%) | |||||||
|---|---|---|---|---|---|---|---|
| Dataset | Data type | Description | Sample size (n) | Overall prevalence | Low intensity | Moderate intensity | High intensity |
| 1 | Uganda longitudinal baseline to year 3 | Full longitudinal data set | 747 | 43.0 | 16.6 | 11.4 | 15.0 |
| 2 | Uganda longitudinal baseline to year 3 | 4a Ugandan districts out of 7 | 400 | 46.5 | 15.5 | 12.3 | 18.8 |
| 3 | Uganda cross-sectional baseline to year 3 | Varying sample size per year, full programme data | Baseline: 4,222; Year 1: 3,973; Year 2: 4,192; Year 3: 3,373 |
45.2 | 16.0 | 11.7 | 17.6 |
| 4 | Mali longitudinal baseline to year 2 | Full longitudinal data set | 897 | 26.5 | 12.5 | 7.1 | 6.9 |
aThese districts were selected for their wide range of infection intensities and NOT used to the development of matrix C